Groups @ and @ each had high rates of SVR@ , which were noninferior to the reported rate of response to the combination of telaprevir , peginterferon , and ribavirin ( group @ : @ % ; @ % confidence interval , @ % -@ % ; and group @ : @ % ; @ % confidence interval , @ % -@ % ) .